- Home
- CDNA vs BRKL Comparison
CDNA vs BRKL Comparison
Compare CDNA & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- BRKL
- Stock Information
- Founded
- CDNA 1998
- BRKL 1871
- Country
- CDNA United States
- BRKL United States
- Employees
- CDNA N/A
- BRKL N/A
- Industry
- CDNA Medical Specialities
- BRKL Savings Institutions
- Sector
- CDNA Health Care
- BRKL Finance
- Exchange
- CDNA Nasdaq
- BRKL Nasdaq
- Market Cap
- CDNA 1.1B
- BRKL 1.1B
- IPO Year
- CDNA 2014
- BRKL 1998
- Fundamental
- Price
- CDNA $23.95
- BRKL $11.32
- Analyst Decision
- CDNA Buy
- BRKL Buy
- Analyst Count
- CDNA 8
- BRKL 3
- Target Price
- CDNA $27.17
- BRKL $14.17
- AVG Volume (30 Days)
- CDNA 713.3K
- BRKL 972.1K
- Earning Date
- CDNA 02-26-2025
- BRKL 01-29-2025
- Dividend Yield
- CDNA N/A
- BRKL 4.77%
- EPS Growth
- CDNA N/A
- BRKL N/A
- EPS
- CDNA N/A
- BRKL 0.83
- Revenue
- CDNA $312,775,000.00
- BRKL $333,825,000.00
- Revenue This Year
- CDNA $19.85
- BRKL N/A
- Revenue Next Year
- CDNA $11.34
- BRKL $39.48
- P/E Ratio
- CDNA N/A
- BRKL $13.65
- Revenue Growth
- CDNA 5.26
- BRKL 1.47
- 52 Week Low
- CDNA $7.42
- BRKL $8.01
- 52 Week High
- CDNA $34.84
- BRKL $13.15
- Technical
- Relative Strength Index (RSI)
- CDNA 54.91
- BRKL 34.63
- Support Level
- CDNA $22.00
- BRKL $11.41
- Resistance Level
- CDNA $24.06
- BRKL $11.96
- Average True Range (ATR)
- CDNA 1.08
- BRKL 0.32
- MACD
- CDNA 0.33
- BRKL -0.06
- Stochastic Oscillator
- CDNA 83.57
- BRKL 20.18
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.